INS and Hypoglycemia: Metformin has demonstrated its efficiency in lowering blood glucose levels, reducing mild weight problems in people with a high body mass index (BMI), improving insulin sensitivity and insulin secretion, and modulating multiple incretin axis components, all of which have only a minimal risk of hypoglycemia, and regulating triglyceride and cholesterol levels [29,30].